UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000002737
Receipt number R000002520
Scientific Title Cohort study evaluating (neo) adjuvant trastuzumab for HER2 positive breast cancer
Date of disclosure of the study information 2009/11/11
Last modified on 2019/11/21 17:13:20

No. Disposal Last modified on Item of update
1 Insert 2009/11/10 14:13:07
2 Update 2009/11/11 14:18:01 Recruitment status
3 Update 2009/12/22 20:38:25 Recruitment status
4 Update 2009/12/22 20:40:38 Recruitment status
5 Update 2010/02/08 18:54:18 Email1
6 Update 2011/08/31 14:25:38 Recruitment status
7 Update 2012/11/11 14:36:13 Post marketing survey by drug manufacture etc., specified by Japanese law.
8 Update 2013/06/17 16:38:13 Acronym
Acronym
9 Update 2013/06/17 16:38:57 Institute
Organization
10 Update 2013/06/17 16:56:52 Organization
11 Update 2015/05/11 12:04:09 Email
12 Update 2015/05/11 12:35:40 Date of closure to data entry
Date trial data considered complete
Publication of results
Results
Results
13 Update 2016/07/06 09:40:53 Address
Address
TEL
Name of primary person or sponsor
Organization
14 Update 2017/05/17 09:11:18 Date of protocol fixation
Date analysis concluded
Results
15 Update 2017/05/17 18:27:04 Results
Results
16 Update 2017/11/16 13:35:28 Recruitment status
Results
Results
17 Update 2018/08/23 17:34:27 Public title
18 Update 2019/11/21 17:07:55 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Zip code

Last name of contact person

Last name of contact person
Organization
Zip code
Address
Homepage URL
Name of person sending information
Name of person sending information
Organization
Division name
Division name
Address
Address
TEL
Email
Institute
Organization
Organization
Organization
Address
Address
Tel
Email
19 Update 2019/11/21 17:13:20 Date of IRB